Pediatric living-related renal transplantation under tacrolimus as the primary immunosuppressive agent.
Ushigome
H
H
Department of Organ Transplant and Endocrine Surgery, Kyoto Prefectural University of Medicine, Kyoto City, Japan.
Okamoto
M
M
Kadotani
Y
Y
Nakamura
K
K
Akioka
K
K
Ohmori
Y
Y
Yoshimura
N
N
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005190:Family; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D016559:Tacrolimus / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016559:Tacrolimus